Industry News
T2 Biosystems expands its leadership in direct-from-whole-blood detection of sepsis-causing pathogens
T2 Biosystems announces plans to license its proprietary technology to accelerate the broad adoption of direct-from-whole-blood diagnostics, generate non-dilutive capital, and create a new royalty revenue stream